Partner Content Partner Content Preliminary Attendee List Released for Orphan Drugs & Rare D... Attendees Released for Orphan Drugs & Rare Diseases
Partner Content Partner Content Only 4 Weeks Until Orphan Drugs & Rare Diseases 2018 Pharma Giants Unite to Improve Rare Disease Treatment
Partner Content Partner Content Carina Schey, University of Groningen, Orphan Drugs & Ra... Chair Invitation to Orphan Drugs & Rare Diseases 2018
Views & Analysis Why AI and blockchain are the solutions to developing orphan... We are in the midst of a significant shift in pharmaceutical drug development, with many leading companies focusing increasingly on orphan drugs targeted at small niche markets.
Partner Content Partner Content How challenges like Brexit & insufficient patients hinde... Challenges facing Orphan Drugs & Rare Diseases Research
Events Partner Content Orphan Drugs & Rare Diseases 2018 Orphan Drugs & Rare Diseases 2018 Conference
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
